<HashMap><database>iProX</database><scores/><additional><omics_type>Proteomics</omics_type><submitter>Dezhi Kong</submitter><species>Mus Musculus</species><full_dataset_link>http://www.iprox.org/page/project.html?id=IPX0012512000</full_dataset_link><submitter_email>kongdezhi@hebmu.edu.cn</submitter_email><submitter_affiliation>Hebei Medical University</submitter_affiliation><sample_protocol></sample_protocol><repository>iProX</repository><data_protocol></data_protocol></additional><is_claimable>false</is_claimable><name>Glycosylation Inhibition as a Therapeutic Strategy for Neuroinflammatory Disorders: The Potential of Tanshinone IIA</name><description>Our study employed a combined proteomic and glycoproteomic approach to investigate the role of protein glycosylation in lipopolysaccharide (LPS)-induced neuroinflammation models. Bioinformatics analysis of the proteomic and glycoproteomic data further emphasized a strong connection between our observed changes and pathways implicated in glycosylation and neuroinflammation.</description><dates><publication>Thu Jul 10 00:00:00 BST 2025</publication></dates><accession>PXD065987</accession><cross_references><TAXONOMY>10090</TAXONOMY></cross_references></HashMap>